Platelet aggregation inhibitors

A drug may be classified by the chemical type of the active ingredient or by the way it is used to treat a particular condition. Each drug can be classified into one or more drug classes.

Platelet aggregation inhibitors work in different places of the clotting cascade and prevent platelet adhesion, therefore no clot formation.

Aspirin, the most commonly used antiplatelet drug changes the balance between prostacyclin (which inhibits platelet aggregation) and thromboxane (that promotes aggregation). It irreversibly inhibits the enzyme cyclo-oxygenase, which leads to reduction in thromboxane synthesis in platelets and prostacyclin in vascular endothelial cells. The vascular endothelium recovers and can synthesize more prostacyclin but thromboxane synthesis only recovers after new platelets are formed.

Platelet aggregation inhibitors are used acutely in myocardial infarction, atrial fibrillation, following coronary bypass, angioplasty and stenting. It is also used as prophylaxis to prevent myocardial infarction and stroke.

Filter by:
Drug Name DownUp( View by: Brand | Generic ) Reviews Avg. Ratings DownUp
cilostazol systemic (Pro, More...)
2 Review(s)
   
Rate It!
10
ticagrelor systemic (Pro, More...)
0 Review(s)
   
Rate It!
10
clopidogrel systemic (Pro, More...)
26 Review(s)
   
Rate It!
9.0
prasugrel systemic (Pro, More...)
6 Review(s)
   
Rate It!
8.8
aspirin / pravastatin systemic (More...)
0 Review(s)
   
Rate It!
8.0
aspirin systemic (Pro, More...)
12 Review(s)
   
Rate It!
7.7
aspirin / dipyridamole systemic (Pro, More...)
8 Review(s)
   
Rate It!
5.4
dipyridamole systemic (Pro, More...)
0 Review(s)
   
Rate It!
0.0
ticlopidine systemic (Pro, More...)
0 Review(s)
   
Rate It!
0.0

See also

Medical conditions associated with platelet aggregation inhibitors:

Advertisement
Close

Recommended

(web1)